Pharmaceutical companies
The list price for the world’s top grossing drug has swelled to as much as $50,000 per patient per year, a United Food and Commercial Workers local said in a federal lawsuit filed in Chicago March 18. AbbVie, the drug’s manufacturer, is using a “thicket” of more than 100 patents to block similar products from entering the market, the union says....